Conference and Matchmaking Location: Konzil Konstanz*
Conference Language: English
Day 1, October 12, 2022
Programme October 12, 2022
10.00
Pre-conference event:
Matchmaking with organized 1-to-1 meetings (only a limited number of tickets available!)
12.30
Registration, exhibition & networking
14.00
Welcome and introduction by BioLAGO
Session 1: The diagnostic laboratory in 2032 - reflecting medical needs in changing health systems
Chair: Dr. Simone Günther, Becton Dickinson (D/US)
14.10
Keynote
A vision of data ecosystem for future diagnostics
Dr. Razvan Ionasec, Amazon Web Services
14.35
Vision Statements: The diagnostic laboratory in 2032
- Cancer perspective: Dr. Simone Günther, Becton Dickinson (D/US)
- Microbiology view: Dr. Oliver Nolte, Center for Laboratory Medicine St. Gallen (CH)
- Diabetes & cardiovascular perspective: Prof. Dr. Andreas Nüssler / Dr. med. Sabrina Ehnert, BG Clinics (D)
15.05
Molecular tumor boards in decentral settings
Prof. Dr. med. Uwe Martens, SLK Clinics Heilbronn / MOLIT Institute (D)
15.25
Plenary discussion
15.35
Coffee break, exhibition & networking
Session 2: Detecting resistance on various levels
Chair: Dr. Michael Steinwand, BioLAGO
16.15
Novel trends for antimicrobial susceptibility testing (AST) of bacterial infection
Prof. Dr. Hans-Peter Deigner, HFU Furtwangen University (D)
16.40
Fully automated quantification of relevant antibiotics - an option for timely Therapeutical Drug Monitoring (TDM) in critically ill patients?
Dr. Matthias Herkert, DRG Instruments GmbH (D) and PD Dr. med. Johannes Zander, Laboratory Dr. Brunner (D)
17.00
Topic: Detecting resistance from the laboratory view
N.N.
17.20
Plenary discussion
17.30
Networking and exhibition
18.00
Conference Dinner
Day 2, October 13, 2022
Programme October 13, 2022
08.00
Registration, exhibition & networking
09.00
Introduction and review of Day 1:
Dr. Michael Steinwand, BioLAGO (D)
Session 3: Cancer & Co. - diagnostics for complex diseases
Chair: Marc Masa, LEITAT Technological Center (ESP)
09.05
Keynote
Orphan diseases: Diagnosis of Hemophagocytic Lymphohistiocytosis (HLH)
Prof. Dr. med. Paul Graf La Rosée, Schwarzwald-Baar Clinics (D)
Dr. Martin Ritthaler, Center for Human Genetics Tuebingen (D)
09.30
Precision medicine for individual cancer immunotherapy
Dr. Marcus Dühren-von Minden, AVA Life Science GmbH (D)
09.50
The importance of determining T-Cell response in vaccinated individuals - overview on an optimized protocol, current practice and future trends beyond Sars-Cov-2
Dr. Gianluca Rotta, BD Biosciences (IT)
10.10
Using single cell analyses for clinical-decision making and their future role in routine diagnostic applications
Dr. Guilhem Tourniaire, Cellenion (F)
10.30
Plenary discussion
10.40
Networking & exhibition
Session 4: AI & Digital diagnostics with focus on prevalent diseases
Chair: Prof. Dr. Klazine van der Horst, Bern University of Applied Sciences (CH)
11.15
Keynote
Concepts for therapeutical home monitoring
Prof. Dr. med. Christiane Brockes, alcare AG (CH)
11.40
Covid-19 infection: rapid detection via wearables
Kirsten Grossmann-von Haugwitz, Dr. Risch (LI/CH)
12:00
Bridging the gap between routine diagnostics and -omics data: implementation of AI assisted decision making
Jan Kirchhoff, medicalvalues GmbH (D)
12.20
Topic: Digital pathology and AI for cancer screening
Prof. Dr. John O'Leary, Trinity College Dublin (IRL)
12.40
Plenary discussion
12.50
Conference lunch & exhibition
Session 5: Pitching topics from the white board (interactive session)!
Chair: Prof. Dr. David Drissner, Albstadt-Sigmaringen University (D) / BioLAGO
14.15
Pitch presentations - voted by the attendees
Post your ideas for better diagnostics. Voted by the attendees, the 5 most brilliant contributions get the chance for a pitch presentation on stage.
Whether graduate, researcher, start-up or experienced company - everyone can take part. More information.
15:30
Closing remarks and networking apéro
*The Conference will take place physically ensuring a safe participation during the coronavirus pandemic. For more information, please see our full Hygiene and Safety Measures.